Correlation Between Equillium and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Equillium and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and Molecular Partners AG, you can compare the effects of market volatilities on Equillium and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Molecular Partners.
Diversification Opportunities for Equillium and Molecular Partners
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Equillium and Molecular is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Equillium i.e., Equillium and Molecular Partners go up and down completely randomly.
Pair Corralation between Equillium and Molecular Partners
Allowing for the 90-day total investment horizon Equillium is expected to generate 1.23 times more return on investment than Molecular Partners. However, Equillium is 1.23 times more volatile than Molecular Partners AG. It trades about 0.03 of its potential returns per unit of risk. Molecular Partners AG is currently generating about 0.02 per unit of risk. If you would invest 89.00 in Equillium on September 13, 2024 and sell it today you would lose (19.00) from holding Equillium or give up 21.35% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Equillium vs. Molecular Partners AG
Performance |
| Timeline |
| Equillium |
| Molecular Partners |
Equillium and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Equillium and Molecular Partners
The main advantage of trading using opposite Equillium and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
| Molecular Partners vs. Puma Biotechnology | Molecular Partners vs. Iovance Biotherapeutics | Molecular Partners vs. Sarepta Therapeutics | Molecular Partners vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |